Deny Amgen’s ‘dangerous’ patent claims, Sanofi urges Supreme Court

07-02-2023

Liz Hockley

Deny Amgen’s ‘dangerous’ patent claims, Sanofi urges Supreme Court

French pharma firm urges US court not to allow ‘monopoly’ over market | Enablement issue at centre of antibody patent case could have wide implications for pharma and life sciences industries.


Amgen’s, Deny, patent, Sanofi, asks, Supreme, Court, Sanofi, Amgen, US supreme Court, patent, infringement

LSIPR